Last reviewed · How we verify
PEG 4L
PEG 4L is a polyethylene glycol used as a solubilizing agent in pharmaceutical formulations.
At a glance
| Generic name | PEG 4L |
|---|---|
| Also known as | Bohm® |
| Sponsor | Parc de Salut Mar |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
PEG 4L is a type of polyethylene glycol that is commonly used to improve the solubility of poorly soluble drugs. This is achieved by forming a complex with the drug, allowing it to be more easily absorbed by the body.
Approved indications
Common side effects
Key clinical trials
- Impact of Chewing Gum on Bowel Preparation in Patients Undergoing Colonoscopy (NA)
- Effect of Non-invasive Neuromodulation on the Quality of Intestinal Cleansing (NA)
- Efficacy, Tolerance and Safety of Split Dose Bowel Preparation for Colonoscopy: 4L Polyethylene Glycol (PEG) Versus 1L Polyethylene Glycol Plus Sodium Picosulfate-magnesium Citrate (SPMC) (PHASE4)
- Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery (PHASE1)
- Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing (NA)
- Technical Feasibility Evaluation of Mucosal Staining During Colon Capsule Endoscopy (CCE) Procedure in Colorectal Cancer (CRC) High Risk Population, When Using MB-MMX (NA)
- Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer Surgery (NA)
- Optimization of Intestinal Preparation in Older Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PEG 4L CI brief — competitive landscape report
- PEG 4L updates RSS · CI watch RSS
- Parc de Salut Mar portfolio CI